Latest Articles
Cumbrian brewery to release new beer for International Women's Day - The Mail
Cumbrian brewery to release new beer for International Women's Day The Mail
Published: March 6, 2025, 5 a.m.
newsGP - In Practice: Be prepared for 2025 flu season - RACGP
newsGP - In Practice: Be prepared for 2025 flu season RACGP
Published: March 6, 2025, 4:34 a.m.
Docs slam 'band-aid' fixes for 'period disease' - MD Linx
Docs slam 'band-aid' fixes for 'period disease' MD Linx
Published: March 6, 2025, 3:11 a.m.
ABC-7 at : Local doctor explains the link between endometriosis and heart disease - KVIA
ABC-7 at : Local doctor explains the link between endometriosis and heart disease KVIA
Published: March 6, 2025, 12:36 a.m.
Taylour Paige-Angulo Says Her Pain from This Common Condition Was So Bad It 'Would Make Me See Stars' - PEOPLE
Taylour Paige-Angulo Says Her Pain from This Common Condition Was So Bad It 'Would Make Me See Stars' PEOPLE
Published: March 5, 2025, 8:06 p.m.
ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer - Medpage Today
ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer Medpage Today
Published: March 5, 2025, 4:47 p.m.
Women claim they were needlessly sterilized by East Memphis doctor facing federal charges - MSN
Women claim they were needlessly sterilized by East Memphis doctor facing federal charges MSN
Published: March 5, 2025, 4:22 p.m.
20 years ago I'd be dead - but I've beaten cancer & doing Race for Life - Lancashire Evening Post
20 years ago I'd be dead - but I've beaten cancer & doing Race for Life Lancashire Evening Post
Published: March 5, 2025, 3:08 p.m.
Experts and patients talk pregnancy, gynecology conditions and more in new podcast series - Sunnybrook Hospital
Experts and patients talk pregnancy, gynecology conditions and more in new podcast series Sunnybrook Hospital
Published: March 5, 2025, 2:49 p.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com
Published: March 5, 2025, 11:04 a.m.
Link copied to clipboard!